ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
HoldingPattern
|
28 |
4.6K |
3 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
28
|
4.6K
|
3
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
HoldingPattern
|
1.0K |
269K |
11 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
1.0K
|
269K
|
11
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
HoldingPattern
|
165 |
45K |
14 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
165
|
45K
|
14
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
HoldingPattern
|
165 |
45K |
9 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
165
|
45K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
HoldingPattern
|
165 |
45K |
13 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
165
|
45K
|
13
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Sustained Reduction in Tumour Size Seen In Pancreatic Trial
|
|
HoldingPattern
|
45 |
9.5K |
8 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
45
|
9.5K
|
8
|
|
ASX - By Stock
|
PER |
Re:
CMO interview not to be missed
|
|
HoldingPattern
|
58 |
15K |
23 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
58
|
15K
|
23
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Trading Halt
|
|
HoldingPattern
|
75 |
22K |
14 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
75
|
22K
|
14
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Trading Halt
|
|
HoldingPattern
|
75 |
22K |
5 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
75
|
22K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Trading Halt
|
|
HoldingPattern
|
75 |
22K |
13 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
75
|
22K
|
13
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 x LDX product distribution
|
|
HoldingPattern
|
4 |
2.0K |
5 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
4
|
2.0K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis
|
|
HoldingPattern
|
88 |
31K |
2 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
88
|
31K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Syntara the science explained
|
|
HoldingPattern
|
68 |
20K |
2 |
26/05/24 |
26/05/24 |
ASX - By Stock
|
68
|
20K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity to Present New ATH434 Data at Orphan Drug Congress
|
|
HoldingPattern
|
29 |
9.5K |
5 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
29
|
9.5K
|
5
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: AT1 secures significant order for HIV self tests for LMIC
|
|
HoldingPattern
|
67 |
23K |
15 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
67
|
23K
|
15
|
|
ASX - By Stock
|
ATX |
Re:
Ann: FDA Clearance Amplia's IND for Pancreatic Cancer Trial in US
|
|
HoldingPattern
|
21 |
8.0K |
2 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
21
|
8.0K
|
2
|
|
ASX - By Stock
|
GUE |
Re:
General Discussion GUE
|
|
HoldingPattern
|
95 |
33K |
2 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
95
|
33K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
HoldingPattern
|
1.0K |
402K |
3 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
402K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Significant Purchase Order for HIV Self-Tests for Europe
|
|
HoldingPattern
|
14 |
7.6K |
3 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
14
|
7.6K
|
3
|
|
ASX - By Stock
|
OVT |
Re:
Ann: IOU Announces SPP Launch, Booklet & Timetable
|
|
HoldingPattern
|
74 |
29K |
3 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
74
|
29K
|
3
|
|
ASX - By Stock
|
OVT |
Re:
$1 Club
|
|
HoldingPattern
|
32K |
9.4M |
5 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
32K
|
9.4M
|
5
|
|
ASX - By Stock
|
OVT |
Re:
IOU Chart
|
|
HoldingPattern
|
2.1K |
781K |
17 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
2.1K
|
781K
|
17
|
|
ASX - By Stock
|
BOE |
Re:
Ann: Boss Operational Update
|
|
HoldingPattern
|
26 |
13K |
0 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
26
|
13K
|
0
|
|
ASX - By Stock
|
LDX |
Re:
LDX Price Target $1.0
|
|
HoldingPattern
|
19 |
5.3K |
2 |
04/10/21 |
04/10/21 |
ASX - By Stock
|
19
|
5.3K
|
2
|
|
ASX - By Stock
|
VMY |
Re:
Ann: Managing Director & CEO Change
|
|
HoldingPattern
|
245 |
70K |
3 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
245
|
70K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Appendix 4E and Full Year Statutory Accounts
|
|
HoldingPattern
|
42 |
12K |
4 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
42
|
12K
|
4
|
|
ASX - By Stock
|
AUA |
Re:
Audeara Limited IPO
|
|
HoldingPattern
|
41 |
19K |
0 |
08/07/21 |
08/07/21 |
ASX - By Stock
|
41
|
19K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
HoldingPattern
|
2.4K |
781K |
4 |
07/07/21 |
07/07/21 |
ASX - By Stock
|
2.4K
|
781K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Access Bio receives FDA clearance for COVID-19 antibody test
|
|
HoldingPattern
|
50 |
15K |
5 |
28/06/21 |
28/06/21 |
ASX - By Stock
|
50
|
15K
|
5
|
|
ASX - By Stock
|
AT1 |
Re:
Let's go to moon !
|
|
HoldingPattern
|
11 |
4.8K |
0 |
26/06/21 |
26/06/21 |
ASX - By Stock
|
11
|
4.8K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
HoldingPattern
|
2.4K |
781K |
4 |
25/06/21 |
25/06/21 |
ASX - By Stock
|
2.4K
|
781K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
HoldingPattern
|
2.4K |
781K |
11 |
24/06/21 |
24/06/21 |
ASX - By Stock
|
2.4K
|
781K
|
11
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
HoldingPattern
|
2.4K |
781K |
11 |
22/05/21 |
22/05/21 |
ASX - By Stock
|
2.4K
|
781K
|
11
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
HoldingPattern
|
2.4K |
781K |
1 |
08/05/21 |
08/05/21 |
ASX - By Stock
|
2.4K
|
781K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
HoldingPattern
|
2.4K |
781K |
0 |
08/05/21 |
08/05/21 |
ASX - By Stock
|
2.4K
|
781K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
HoldingPattern
|
2.4K |
781K |
3 |
28/01/21 |
28/01/21 |
ASX - By Stock
|
2.4K
|
781K
|
3
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Assays Confirm Major Copper Discovery at Big One Deposit
|
|
HoldingPattern
|
319 |
110K |
9 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
319
|
110K
|
9
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
HoldingPattern
|
2.4K |
781K |
0 |
04/01/21 |
04/01/21 |
ASX - By Stock
|
2.4K
|
781K
|
0
|
|
ASX - By Stock
|
CCZ |
Re:
Now is the time - Copper back to June 2018 prices - $7000 per tonne
|
|
HoldingPattern
|
495 |
122K |
18 |
01/12/20 |
01/12/20 |
ASX - By Stock
|
495
|
122K
|
18
|
|
ASX - By Stock
|
AZS |
Re:
Ann: Trading Halt
|
|
HoldingPattern
|
29 |
9.2K |
1 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
29
|
9.2K
|
1
|
|
ASX - By Stock
|
CCZ |
Re:
Presentation - should watch
|
|
HoldingPattern
|
38 |
12K |
12 |
19/10/20 |
19/10/20 |
ASX - By Stock
|
38
|
12K
|
12
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Drilling logistics largely finalised at Mt Oxide Project
|
|
HoldingPattern
|
107 |
35K |
0 |
13/10/20 |
13/10/20 |
ASX - By Stock
|
107
|
35K
|
0
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Drilling logistics largely finalised at Mt Oxide Project
|
|
HoldingPattern
|
107 |
35K |
6 |
10/10/20 |
10/10/20 |
ASX - By Stock
|
107
|
35K
|
6
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Drilling logistics largely finalised at Mt Oxide Project
|
|
HoldingPattern
|
107 |
35K |
11 |
10/10/20 |
10/10/20 |
ASX - By Stock
|
107
|
35K
|
11
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Eldorado Prospective for Structurally Controlled Copper
|
|
HoldingPattern
|
47 |
11K |
2 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
47
|
11K
|
2
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Eldorado Prospective for Structurally Controlled Copper
|
|
HoldingPattern
|
47 |
11K |
1 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
47
|
11K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
HoldingPattern
|
13K |
5.0M |
18 |
29/09/20 |
29/09/20 |
ASX - By Stock
|
13K
|
5.0M
|
18
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: High Grade Copper and Gold Identified at Big One
|
|
HoldingPattern
|
128 |
40K |
1 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
128
|
40K
|
1
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: High Grade Copper and Gold Identified at Big One
|
|
HoldingPattern
|
128 |
40K |
4 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
128
|
40K
|
4
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: High Grade Copper and Gold Identified at Big One
|
|
HoldingPattern
|
128 |
40K |
7 |
19/09/20 |
19/09/20 |
ASX - By Stock
|
128
|
40K
|
7
|
|